Skip to content

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program Tailored for Men

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04104243
Acronym
Power-Up
Enrollment
301
Registered
2019-09-26
Start date
2021-08-09
Completion date
2025-02-07
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Diabetes, Type 2 Diabetes

Keywords

Pre-Diabetes, Men's Health, Type 2 Diabetes, Racial Disparities

Brief summary

The goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.

Detailed description

The rising epidemic of type 2 diabetes is a major cause of disability and death that disproportionately affects men. Compared to women, men have much worse health and higher death rates for several chronic conditions, including diabetes. The National Diabetes Prevention Program (NDPP) has been shown to help decrease the chances of developing type 2 diabetes. The NDPP has shown the value of lifestyle change for weight loss and diabetes prevention. The Power-Up study is being done because although the evidence points to the effectiveness of the Diabetes Prevention Program (DPP), men are less likely to be engaged or participate in DPP. The Power-up study was designed to see whether a DPP tailored for men can help improve engagement, participation, and results for men. Participants will be randomized to either undergo the Power-Up or standard NDPP classes. An assessment of whether a DPP created for men will increase participation in the program and decrease the risk for diabetes as compared to the standard NDPP. Power-Up is designed to Aim 1) Assess the effect of Power-Up vs. standard care NDPP on percent weight loss among men at risk for diabetes; Aim 2) Compare engagement of minority men at risk for diabetes in Power-Up vs. standard care NDPP; and Aim 3) Evaluate the Reach, Effectiveness, Adoption, Implementation, and Costs of Power-Up using the RE-AIM framework. The Power-Up intervention is tailored to the needs and preferences of men and uses: a) men coaches; b) men-only groups; c) messaging tailored to be appreciated and motivational to men; d) adapted content that highlights issues relevant to men. There are 22-28 classes over the course of 12 months for both Power-Up and standard NDPP. The classes are split into two phases which are called the core and the maintenance phases. The core phase of the program will consist of at least 16 classes over the first 6 months. After the core, participants will attend maintenance classes over the next 6 months. Participants will be asked over the course of the 12 months to complete surveys at three different times before, during, and after completing the classes. The hypothesis is that men randomized to Power-Up will achieve significantly greater weight loss (% weight loss from baseline) at 16 weeks and 1 year than men randomized to the standard care, mixed-gender NDPP group (Aim 1). Evaluation of engagement and retention for Aim 2 is based on attendance records for Power-Up and NDPP sessions electronically collected by trained coaches and monitored by study staff. The standards will be followed for NDPP evaluation where engagement is defined as equal or greater than 4 core sessions attended and retention is defined as equal or greater than 9 sessions attended. There will be a collection of quantitative and qualitative data that will be rigorously evaluated: the reach of our recruitment, broader patient-important indicators of effectiveness, adoption at the practice level, and implementation of the intervention (Aim 3). Enrollment consists of 300 participants through our health system partners. Men will be randomized 1:1 to either the Power-Up intervention arm or referred to the standard NDPP at their clinic site. Consistent with current Centers for Disease Control and Prevention (CDC) standards and current NDPP practices of our health system partners, telephone make-up sessions will be offered by coaches in both conditions to men who miss in-person sessions.

Interventions

OTHERMen-Tailored DPP (Power-Up)

Evaluating whether a diabetes prevention program (DPP) tailored for men (Power-Up) will show better or similar percent weight loss and retention than a standard mixed-gender DPP

Sponsors

Albert Einstein College of Medicine
Lead SponsorOTHER
New York City Department of Health and Mental Hygiene
CollaboratorOTHER_GOV
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

There will be 6 intervention cycles. Approximately 50 men will be randomized 1:1 to each study arm. There will be 4 control cycles for every intervention workshop. Therefore we will have 6 intervention workshops and 24 control workshops. The participants will be randomized to either undergo Power-Up or standard Diabetes Prevention Program sessions.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years old * Most recent HbA1c: 5.7%-6.4% (within last year) or Diabetes Risk Score \>= 5 * Most recent BMI ≥ 25 (within last 6 months) * Access to a device that can join sessions virtually either through a virtual conferencing application * Have valid address and telephone contact information * Have no plans to change their health system/primary care provider or move from their current, NYC area, address in the next year

Exclusion criteria

* Not physically able or willing to attend virtual, group-based sessions * Unable to provide informed consent by telephone * Unable or unwilling to complete baseline telephone surveys or follow-up surveys in English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Percent Weight Change Through 16 SessionsUp to 6 months, after the delivery of the 16th session (end of the core phase)The percent weight change through 16 sessions was compared. Mean percent weight change for each arm for all intent-to-treat (ITT) participants (i.e.. attended \>=0 sessions), as well as those who were considered "Engaged" (i.e., attended \>=4 sessions) or "Retained" (i.e., attended \>=9 sessions), through 16 scheduled sessions, was determined. All data is crude and unadjusted with no imputation.
Percent Weight Change Through the 12 Month Trial12 Months (At end of maintenance phase)The percent weight change through 12 months was compared. Mean percent weight change for each arm for all intent-to-treat (ITT) participants (i.e., attended \>=0 sessions), as well as those who were considered "Engaged" (i.e., attended \>=4 sessions) or "Retained" (i.e., attended \>=9 sessions), through 12 months, was determined. All data is crude and unadjusted with no imputation.

Secondary

MeasureTime frameDescription
Engagement of Men in Power-Up vs Standard National Diabetes Prevention Program6 Months (At end of the core phase)Engagement of men at risk for diabetes in Power-Up vs. Standard NDPP was compared based on the number of sessions attended. Engagement is characterized as attending \>= 4 sessions. Counts and percentages of participants who attended at least 4 sessions in the first six months of the workshops are summarized by study arm. This is halfway through the entire trial.
Retention of Men in Power-Up vs Standard National Diabetes Prevention Program12 Months (At end of the maintenance phase)Retention of men at risk for diabetes in Power-Up vs. Standard NDPP was compared based on the number of sessions attended. Participants are defined as "retained" if they attended \>=9 more sessions. It is expected that men randomized to the Power-Up sessions will have greater engagement and retention rates than men randomized to standard care and referred to mixed-gender NDPP classes. Counts and percentages of participants who attended at least 9 sessions through the 12 months of workshops are summarized by study arm.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREarle Chambers, PhD

Albert Einstein College of Medicine

Participant flow

Recruitment details

Using the electronic health record (EHR) systems of a large academic medical center and a network of small to medium independent primary care practices throughout New York City, Black and Latino men who met eligibility criteria for NDPP were identified and enrolled in a randomized controlled trial and assigned 1:1 to receive Power-Up or the standard, mixed-gender NDPP over 1 year via online videoconferencing. The participants were recruited over the phone.

Pre-assignment details

The study team began with a total of N=11052 participants (Ps). We were unable to contact n=6235 Ps. Before screening, n=1489 Ps declined to participate, and n=486 Ps were lost to follow-up. During screening, n=476 Ps were ineligible, and n=1739 Ps were eligible and declined to consent. After consent, n=326 Ps were lost to follow-up and not randomized. Enrolled is defined, according to the protocol, as being randomized into one of the study arms. Only 301 Ps were randomized.

Baseline characteristics

Characteristic
Age, Continuous53.226 Years
STANDARD_DEVIATION 12.737
Age, Customized
Age at First Session
52.1 Years
STANDARD_DEVIATION 12.5
Baseline Body Mass Index (BMI)33.4 kg/m^2
STANDARD_DEVIATION 7.3
Baseline Weight211.5 Pounds
STANDARD_DEVIATION 43.6
Born in US
No
153 Participants
Born in US
Yes
72 Participants
Current Smoking Frequency
Daily
12 Participants
Current Smoking Frequency
Not at all
259 Participants
Current Smoking Frequency
Some Days
15 Participants
Delay between Randomization and Start47.5 days
STANDARD_DEVIATION 31.8
Employment Status
Not Reported
3 Participants
Employment Status
Not working, but looking for work
20 Participants
Employment Status
Not working, not looking for work
13 Participants
Employment Status
Not working, unable to work
33 Participants
Employment Status
Perform volunteer work
2 Participants
Employment Status
Retired
40 Participants
Employment Status
Working full-time
145 Participants
Employment Status
Working part-time (including seasonal/work-study, etc.)
42 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
74 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
76 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Ever Smoked
No
95 Participants
Ever Smoked
Yes
60 Participants
Has Health Insurance?
Don't Know/Not Sure
3 Participants
Has Health Insurance?
No
12 Participants
Has Health Insurance?
Yes
141 Participants
Highest Level of Education Completed
Elementary/Primary School (Includes grades 1-5)
2 Participants
Highest Level of Education Completed
High School/Preparatory School
75 Participants
Highest Level of Education Completed
Middle School/Junior High (Includes grades 6-8)
20 Participants
Highest Level of Education Completed
Some College
1 Participants
Highest Level of Education Completed
Trade School/Vocational School
8 Participants
Highest Level of Education Completed
University/College
119 Participants
Household Income
<= $50,000
68 Participants
Household Income
> $50,000
92 Participants
Household Income
Declined to answer
35 Participants
Life Difficulty from PHQ-8 Symptoms
Extremely difficult
4 Participants
Life Difficulty from PHQ-8 Symptoms
Not at all difficult
72 Participants
Life Difficulty from PHQ-8 Symptoms
Somewhat difficult
38 Participants
Life Difficulty from PHQ-8 Symptoms
Very difficult
19 Participants
Marital Status
Divorced
22 Participants
Marital Status
Living with a partner
11 Participants
Marital Status
Married
60 Participants
Marital Status
Separated
6 Participants
Marital Status
Single
51 Participants
Marital Status
Widow(er)
2 Participants
Number of People Supported on Household Income2.6 People
STANDARD_DEVIATION 1.6
Personal Health Questionnaire (PHQ-8) score5.2 score on a scale
STANDARD_DEVIATION 5
Race/Ethnicity, Customized
Race
American Indian/Alaska Native
3 Participants
Race/Ethnicity, Customized
Race
Black
85 Participants
Race/Ethnicity, Customized
Race
Multiracial
14 Participants
Race/Ethnicity, Customized
Race
Other
61 Participants
Race/Ethnicity, Customized
Race
Pacific Islander/Native Hawaiian
0 Participants
Race/Ethnicity, Customized
Race
White
14 Participants
Region of Enrollment
United States
301 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
301 Participants
Source of Health Insurance
Medicaid including Medicaid Managed Care
110 Participants
Source of Health Insurance
Medicare
18 Participants
Source of Health Insurance
Other/Unknown
18 Participants
Source of Health Insurance
Private
51 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 1550 / 146
other
Total, other adverse events
0 / 1550 / 146
serious
Total, serious adverse events
0 / 1550 / 146

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026